Webing on pathologic examination of human kidneys affected by cisplatin toxicity. Both proximal and distaltubulesareaffected,andinpatientswithAKI, there is usually acute tubular necrosis. Long-term cisplatin exposure may also cause cyst formation and interstitial fibrosis (Figure 1) (3). Patients with cisplatin toxicity typically present WebTubular epithelial cells (TECs) is one of the most damaged cells in cisplatin induced AKI ( Xu et al., 2015 ). The well-known mechanism by which cisplatin exerts its anticancer effects—DNA damage—also affecting renal cells ( Tchounwou et al., 2024 ).
The use of cisplatin in patients after kidney... : Medicine
WebApr 12, 2024 · The main risk factors related to the AKI onset in neoplastic patients are the (i) metabolic alterations associated with cancer (such as tumor lysis syndrome-TLS, uric acid nephropathy and hypercalcemia), (ii) the hematopoietic stem-cell transplantation (HSCT) that is often complicated by AKI, (iii) the use of nephrotoxic chemotherapeutic agents … WebDec 3, 2024 · One in four patients treated with cisplatin develop chronic kidney disease. The Yale researchers found that by using an agonist peptide, derived from the secreted … flowfit systemrohr
Yale Scientists Seek to Shift Treatment of Kidney Damage
WebCisplatin dose adjustment in patients with renal impairment must be improved. Estimating GFR with the aMDRD formula and adding an intermediary level of dose reduction for patients with eGFR from 50 to 59.9 mL/min may result in a higher cumulative dose of cisplatin without higher renal toxicity, whic … WebAug 24, 2024 · Damage to non-cancer cells can occur while the body works to metabolize and excrete the drug. “Although the body excretes 50% to 80% of the administered cisplatin within a day or so, some remains in the kidney, where it damages specific cells in the nephron, which removes waste from the blood before it is converted to urine,” Dr. Zhao … WebMay 8, 2024 · Nephrotoxicity With Cisplatin Patients may accumulate metabolites in the renal proximal tubule cells of the kidneys, where 90% of cisplatin undergoes urinary excretion, Duffy et al. explained. This causes a trifecta of factors: direct inflammation, production of reactive oxygen species leading to oxidative cell damage, and cell death. greencar.com